Week of February 7, 2023 | Vol. 12, Issue 5

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners

SCOPE Summit for Clinical Ops Executives

February 6-9, 2023 - Orlando, FL

CHPA 2023

March 19-21, 2023 - Orlando, FL

DCAT Week 2023

March 20-23, 2023 - New York City, NY

CPHI-North-America-logo-web image
en_bnr_home_global01 image

CPHI North America

April 25-27, 2023 - Philadelphia, PA

INTERPHEX 2023

April 25-27, 2023 - New York City, NY

INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A TRANSACTIONS

Pharma & Biotech

9 transactions totaling $98 million


Supplies, Equipment & Services

23 transactions totaling $150 million


Healthcare Facilities & Distributors

7 transactions totaling $118 million


Healthcare IT & Managed Care

1 transaction

PRIVATE PLACEMENTS

Pharma & Biotech

22 transactions totaling $353 million


Supplies, Equipment & Services

21 transactions totaling $123 million


Healthcare Facilities & Distributors

5 transactions


Healthcare IT & Managed Care

9 transactions totaling $126 million

PUBLIC OFFERINGS

Pharma & Biotech

19 transactions totaling $608 million


Supplies, Equipment & Services

9 transactions totaling $130 million


Healthcare Facilities & Distributors

0 transactions


Healthcare IT & Managed Care

3 transactions totaling $2.6 billion

TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.






MARKET REPORTS
Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

CVS Health launches initiative with Meharry Medical College, Sinai Chicago aiming to reduce disparities in marginalized communities

Fierce Healthcare - Jan 30, 2023

New CDMO Vector BioMed Launches Operations

Contract Pharma - Feb 1, 2023

Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss

Contract Pharma - Feb 1, 2023

Lonza Breaks Ground on Commercial Drug Product Facility in Stein

Contract Pharma - Feb 1, 2023

Carbogen Amcis Opens Sterile Liquid Drug Product Mfg. Facility in France

Contract Pharma - Feb 2, 2023

Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity

Contract Pharma - Feb 3, 2023

TANNER NEWS

Linkedin  

Yes We Have, Yes We Will

Last year, our Global Access Programs division alone supported patients in 49 countries, supplying over 350,000 units of life-improving medicines. Learn more about our access programs here.

Medical Products in LATAM

The availability of pharmaceuticals can be limited in certain emerging markets. LATAM is one such region, where regulatory, political and economic obstacles can present challenges with commercial launch and supply. Read more about Tanner is addressing these issues and getting patients access to the medicine they need. Read more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.